Address: C76, Balewadi, Pune, Maharashtra
“Canine Atopic Dermatitis Market, Size, Share, Opportunities Analysis, By Type (Glucocorticoids, Antihistamines, Others, By Mode of Administration (Topical, Oral, Injectable), By Distribution Channel (Veterinary Hospitals/Clinics, Retail, E-commerce), and By Region regional forecast, 2020-2028.”
The global Canine Atopic Dermatitis market is anticipated to expand at a CAGR of 9.1% between 2020 and 2028. One of the major drivers of the global Canine Atopic Dermatitis market is the rise in the occurrence of atopic dermatitis in dogs. The increase in the levels of air pollution along with allergens have improved the market revenue
The developed healthcare infrastructure for Veterinary use, increase in the demand for pet insurance and rising awareness among pet owners have positively impacted the market
Key trends of global Canine Atopic Dermatitis market
The players of the Canine Atopic Dermatitis Market are fragmented. Canine Atopic Dermatitis companies focus more on product launches, new innovations, collaborations, mergers, and acquisitions. Zoetis, Elanco, Virbac, AB Science, Boehringer Ingelheim, Toray Industries, and Kindred Biosciences are the key players of the global Canine Atopic Dermatitis market.
Table of Segmentation:
ATTRIBUTE | DETAILS |
Study Period | 2019-2028 |
Unit | Value (USD Billion) |
Market scope | By Product
· Glucocorticoids · Antihistamines · Others |
By Mode of Administration
· Topical · Oral · Injectable |
|
By Distribution Channel
· Veterinary Hospitals/Clinics · Retail · E-commerce |
|
By Region
· North America (U.S., Canada, and Mexico) · Europe (U.K., France, Italy, Spain, Germany, Russia, and the Rest of Europe) · Asia-Pacific (China, India, Japan, Australia, and the Rest of Asia- Pacific) · South America, Middle East & Africa (Brazil, South Africa, UAE, and the Rest of the region) |